Navigation Links
Ardea Biosciences Reports Recent Accomplishments and Announces Fourth Quarter and Full-Year 2010 Financial Results
Date:3/11/2011

arned in 2009 and 2010 resulted from the recognition of a portion of the $35 million, upfront, non-refundable license fee under the Bayer agreement and the related reimbursement by Bayer of third-party development costs.  In addition, in 2010, the Company recognized $15.0 million in revenue for the achievement of the first milestone, as well as approximately $0.4 million in sponsored research revenue, under the license agreement with Bayer.  

For the three and twelve months ended December 31, 2010, total operating expenses increased to $17.8 million and $68.6 million, respectively, from $14.4 million and $52.9 million for the same periods in 2009.  Total operating expenses for the three and twelve months ended December 31, 2010 included non-cash stock-based compensation charges of $1.8 million and $10.8 million, or $0.08 per share and $0.49 per share, respectively, as compared to charges of $1.4 million and $5.8 million, or $0.08 per share and $0.32 per share, respectively, for the same periods in 2009. These increased charges were primarily in connection with the departure of certain employees during the third quarter of 2010.  The increase in total operating expenses between the 2009 and 2010 periods was primarily a result of an increase in research and development expense due mainly to the continued development and progression of our clinical and preclinical programs, as well as the above-described increase in non-cash, stock-based compensation expense.

Net loss for the three and twelve months ended December 31, 2010 was $0.6 million and $41.6 million, or $0.03 per share and $1.91 per share, respectively, compared to a net loss for the same periods in 2009 of $6.3 million and $30.9 million, or $0.34 per share and $1.70 per share, respectively.   The decrease in net loss between the three-month periods and the increase in net loss between the twelve-month periods were due primarily to the revenue and operating expen
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Ardea Biosciences to Present Data on Lead MEK inhibitor, RDEA119, at EORTC-NCI-AACR Symposium
2. Ardea Biosciences to Present Data on Gout and Inflammation Programs at the 2008 ACR/ARHP Annual Scientific Meeting
3. Ardea Biosciences to Present at the UBS Global Life Sciences Conference and the Third Annual JMP Securities Healthcare Focus Conference
4. Cardea Technology Inc and Optasia Medical Ltd Announce Plans to Collaborate to Optimize Their Vertebral Fracture Assessment Tools
5. Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference
6. Ardea Biosciences Announces Appointment of Felix J. Baker, Ph.D. to Board of Directors
7. Ardea Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference
8. Ardea Biosciences Awarded a $733,438 Grant from the U.S. Government Under the Patient Protection and Affordable Care Act
9. Ardea Biosciences to Present at Two Upcoming Investor Conferences
10. Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study of RDEA594 in Allopurinol-Refractory Gout Patients
11. Ardea Biosciences Prices Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... The University of Manchester have generated a new star-shaped molecule ... of its kind ever created. , Known as ... create one for over a quarter of a century and ... Chemistry . , Consisting of two molecular triangles, entwined ... interlocked molecules are tiny each triangle is 114 atoms ...
(Date:9/22/2014)... This is a professional and in-depth study on ... in Global and China. The report provides a basic ... chain structure. Global market analysis and Chinese domestic market ... trends and competitive landscape of the market. A comparison ... , The report also focuses on development policies and ...
(Date:9/22/2014)... September 22, 2014 Follow ... to stay young has groomed and nurtured anti-aging ... worldwide. Growing emphasis on appearance maintenance is benefitting ... a neurotoxic protein obtained from the bacterium, Clostridium ... in muscle relaxation. With cosmetic indications for botulinum ...
(Date:9/22/2014)... 22, 2014  Neogen Corporation (Nasdaq: NEOG ... quarter of its 2015 fiscal year, which ended Aug. ... net income of $7,839,000 in the first quarter of ... Oct. 30, 2013, earnings per share in the current ... First quarter revenues increased 15% to $67,599,000, ...
Breaking Biology Technology:m-Phenylenediamine Industry: mPDA Global & China Trend Analysis Now Available at ReportsnReports.com 2m-Phenylenediamine Industry: mPDA Global & China Trend Analysis Now Available at ReportsnReports.com 3Strong Demand for Non-Invasive Cosmetic Procedures Drives the Global Botulinum Toxin Market, According to New Report by Global Industry Analysts, Inc. 2Strong Demand for Non-Invasive Cosmetic Procedures Drives the Global Botulinum Toxin Market, According to New Report by Global Industry Analysts, Inc. 3Neogen reports 13% net income increase 2Neogen reports 13% net income increase 3Neogen reports 13% net income increase 4Neogen reports 13% net income increase 5Neogen reports 13% net income increase 6Neogen reports 13% net income increase 7
... Inc. (Nasdaq: TNGN ) today provided a ... three months ended March 31, 2011. ... is currently conducting an initial clinical trial of its ... bladder cancer patients requiring a urinary diversion following bladder ...
... America, Inc. ( www.cordblood-america.com ) (OTC BB: CBAID), the umbilical ... life saving potential of stem cells to families nationwide and ... in its unique "Afford-A-Cord" storage program from $29 a month ... storing umbilical cord blood stem cells from $2075 to $495 ...
... Nile Therapeutics, Inc. (NASDAQ: NLTX ), a ... today announced that the Company,s securities will cease trading on ... on May 12, 2011.  The Company expects its common stock ... Marketplace following the suspension of trading on the Nasdaq Capital ...
Cached Biology Technology:Tengion Provides Business Update and Reports First Quarter 2011 Financial Results 2Tengion Provides Business Update and Reports First Quarter 2011 Financial Results 3Tengion Provides Business Update and Reports First Quarter 2011 Financial Results 4Tengion Provides Business Update and Reports First Quarter 2011 Financial Results 5Tengion Provides Business Update and Reports First Quarter 2011 Financial Results 6Tengion Provides Business Update and Reports First Quarter 2011 Financial Results 7Cord Blood America Reduces "Afford-A-Cord" Program Charges; New Buyers Anticipated 2Nile Therapeutics to Transition to OTCQB Marketplace 2Nile Therapeutics to Transition to OTCQB Marketplace 3
(Date:9/22/2014)... Yale University researchers are studying a potential new treatment ... disease in which scars develop in the lungs and ... mimic, miR-29, which is delivered to lung tissue intravenously. ... it reversed fibrosis after several days. , The ... EMBO Molecular Medicine . , "The mimic, when injected ...
(Date:9/22/2014)... cog in a plant,s biological clock one that ... temperature. , Transcription factors, or genetic switches, drive gene ... as light, rain, soil quality, or even animals grazing ... isolated one, called FBH1, that reacts to temperature ... in keeping it on a consistent track. , "Temperature ...
(Date:9/22/2014)... Most of the fires captured in this image burn in ... of Okhotsk. Dozens of red hotspots, accompanied by plumes of ... or grey, blows to the east towards the Sea of ... north of this area, swampy forest inhabit the central depression, ... , While large wildfires are common in Russia in the ...
Breaking Biology News(10 mins):Reversing the effects of pulmonary fibrosis 2Genetic switch regulates a plant's internal clock based on temperature 2
... of double-amputee Olympic hopeful Oscar Pistorius give him a clear ... more off what his 400-meter race time would be if ... released to the public for the first time ... in Dallas and Matthew Bundle of the University of Wyoming. ...
... much bigger animals, despite only having a brain the ... University of London. "Animals with bigger brains are ... of Sensory and Behavioural Ecology at Queen Mary,s Research ... Niven. This begs the important question: what are they ...
... regimens and the best efforts of nurses and doctors, about ... infections. But a revolutionary new wound dressing developed at Tel ... Meital Zilberman of TAU,s Department of Biomedical Engineering has developed ... fibers that can be loaded with drugs like antibiotics to ...
Cached Biology News:Oscar Pistorius' artificial limbs give him clear, major advantage for sprint running 2Oscar Pistorius' artificial limbs give him clear, major advantage for sprint running 3Bigger not necessarily better, when it comes to brains 2A second skin 2
Phospho-Chk1 (Ser296) Antibody Shipping Temperature: HOT Storage Temperature: -20C...
...
3M Imidazole Solution 125 ml...
Sheep polyclonal to Melatonin ( Abpromise for all tested applications). Antigen: Melatonin Tg conjugate....
Biology Products: